ARCHIVES

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

This article is from The Cancer Letter archive.

Vol. 28 No. 13 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis

March 16, 1979

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989